|
Market Closed -
Nasdaq
23:00:00 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.430 USD | +1.37% |
|
+1.61% | -8.28% |
| 08-07 | Relmada Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Relmada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RLMD | Delayed | |
CBOE
| RLMD | Real-time | |
|
Börse Stuttgart
| 4E2 | Delayed | |
|
Deutsche Boerse AG
| 4E2 | Delayed | |
|
Tradegate
| 4E2 | Real-time | |
|
Boerse Muenchen
| 4E2 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bullish |
| Resistance | 4.85 | 5.72 | 7.64 |
| Spread/Res. | -8.66% | -22.55% | -42.02% |
| Spread/Supp. | +2.31% | +2.31% | +14.18% |
| Support | 4.33 | 4.33 | 3.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
